Cargando…

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome

OBJECTIVE: The Guillain–Barré syndrome (GBS) is an acute, immune‐mediated disease of peripheral nerves. Plasmablasts and plasma cells play a central role in GBS by producing neurotoxic antibodies. The standard treatment for GBS is high‐dose intravenous immunoglobulins (IVIg), however the working mec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brem, Maarten D., Jacobs, Bart C., van Rijs, Wouter, Fokkink, Willem Jan R., Tio‐Gillen, Anne P., Walgaard, Christa, van Doorn, Pieter A., IJspeert, Hanna, van der Burg, Mirjam, Huizinga, Ruth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331722/ https://www.ncbi.nlm.nih.gov/pubmed/30656191 http://dx.doi.org/10.1002/acn3.687

Ejemplares similares

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS
por: Fokkink, Willem‐Jan R., et al.
Publicado: (2016)

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
por: Thomma, Robin C.M., et al.
Publicado: (2023)

Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain–Barré Syndrome
por: Walgaard, Christa, et al.
Publicado: (2016)

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies
por: Islam, Zhahirul, et al.
Publicado: (2012)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Can Campylobacter coli induce Guillain-Barré syndrome?
por: van Belkum, A., et al.
Publicado: (2008)

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
por: Ruts, Liselotte, et al.
Publicado: (2007)

Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome
por: Winters, Jeffrey L, et al.
Publicado: (2011)

International Validation of the Erasmus Guillain–Barré Syndrome Respiratory Insufficiency Score
por: Doets, Alex Y., et al.
Publicado: (2022)

Transfusion-Related Acute Lung Injury due to Iatrogenic IVIG Overdose in Guillain–Barre Syndrome
por: Ray, Sanghamitra, et al.
Publicado: (2019)

A CASE OF IVIG REFRACTORY GUILLAIN-BARRÉ SYNDROME IN THE SETTING OF SUBCLINICAL COVID-19 INFECTION
por: DELEVEAUX, SPENCER, et al.
Publicado: (2021)

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016)

Circulating Th17, Th22, and Th1 Cells Are Elevated in the Guillain-Barré Syndrome and Downregulated by IVIg Treatments
por: Li, Shujuan, et al.
Publicado: (2014)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Changes in motor nerve excitability in acute phase Guillain‐Barré syndrome
por: Drenthen, Judith, et al.
Publicado: (2021)

Fatigue in neuromuscular disorders: focus on Guillain–Barré syndrome and Pompe disease
por: de Vries, J. M., et al.
Publicado: (2009)

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study
por: Luijten, Linda W G, et al.
Publicado: (2021)

Diagnosis and management of Guillain–Barré syndrome in ten steps
por: Leonhard, Sonja E., et al.
Publicado: (2019)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
por: Islam, Md. Badrul, et al.
Publicado: (2017)

Campylobacter jejuni HS:23 and Guillain-Barré Syndrome, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2009)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Diagnosis of Guillain–Barré syndrome in children and validation of the Brighton criteria
por: Roodbol, Joyce, et al.
Publicado: (2017)

Zika virus and Guillain–Barré syndrome in Bangladesh
por: GeurtsvanKessel, Corine H., et al.
Publicado: (2018)

Small volume plasma exchange for Guillain-Barré syndrome in resource-limited settings: a phase II safety and feasibility study
por: Islam, Badrul, et al.
Publicado: (2018)

Guillain-Barré Syndrome in Suriname; Clinical Presentation and Identification of Preceding Infections
por: Langerak, Thomas, et al.
Publicado: (2021)

Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
por: Zaki, Hany A., et al.
Publicado: (2023)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

High Incidence of Guillain-Barré Syndrome in Children, Bangladesh
por: Islam, Zhahirul, et al.
Publicado: (2011)

Neurofilament light chain as biomarker for axonal damage in Guillain-Barré syndrome
por: Jacobs, Bart C
Publicado: (2021)

Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence?
por: Ramakrishnan, Sri, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_digh875pvlnk9qpmoh47d21626